Global NGAL Antibody Market Growth (Status and Outlook) 2026-2032

January 2026 | 102 pages | ID: G37CC158D919EN
LP Information

Abstracts

The global NGAL Antibody market size is predicted to grow from US$ 133 million in 2025 to US$ 329 million in 2032; it is expected to grow at a CAGR of 14.1% from 2026 to 2032.

NGAL (Neutrophil gelatinase-associated lipocalin) is a small molecule protein expressed in neutrophils and epithelial cells of some tissues and organs, including renal tubules, and is a member of the human lipocalin family. NGAL antibody, or neutrophil gelatinase-associated lipocalin antibody, is a specific antibody against neutrophil gelatinase-associated lipocalin (NGAL), and is of great value in medical research and clinical diagnosis.

United States market for NGAL Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for NGAL Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for NGAL Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key NGAL Antibody players cover Thermo Fisher Scientific, Abcam, Hytest, Enzo Life Sciences, Biorbyt, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?NGAL Antibody Industry Forecast? looks at past sales and reviews total world NGAL Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected NGAL Antibody sales for 2026 through 2032. With NGAL Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NGAL Antibody industry.

This Insight Report provides a comprehensive analysis of the global NGAL Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on NGAL Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global NGAL Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NGAL Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NGAL Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of NGAL Antibody market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Monoclonal Antibody
• Polyclonal Antibody

Segmentation by Application:

• Clinic
• Scientific Research

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Thermo Fisher Scientific
• Abcam
• Hytest
• Enzo Life Sciences
• Biorbyt
• Proteintech
• Biomatik
• Bio-Techne
• MyBioSource
• GenScript
• Bioss
• BioNC

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global NGAL Antibody Market Size (2021-2032)
  2.1.2 NGAL Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for NGAL Antibody by Country/Region (2021, 2025 & 2032)
2.2 NGAL Antibody Segment by Type
  2.2.1 Monoclonal Antibody
  2.2.2 Polyclonal Antibody
  2.2.3 NGAL Antibody Market Size by Type
    2.2.3.1 NGAL Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global NGAL Antibody Market Size Market Share by Type (2021-2026)
2.3 NGAL Antibody Segment by Application
  2.3.1 Clinic
  2.3.2 Scientific Research
  2.3.3 NGAL Antibody Market Size by Application
    2.3.3.1 NGAL Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.3.2 Global NGAL Antibody Market Size Market Share by Application (2021-2026)

3 NGAL ANTIBODY MARKET SIZE BY PLAYER

3.1 NGAL Antibody Market Size Market Share by Player
  3.1.1 Global NGAL Antibody Revenue by Player (2021-2026)
  3.1.2 Global NGAL Antibody Revenue Market Share by Player (2021-2026)
3.2 Global NGAL Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NGAL ANTIBODY BY REGION

4.1 NGAL Antibody Market Size by Region (2021-2026)
4.2 Global NGAL Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas NGAL Antibody Market Size Growth (2021-2026)
4.4 APAC NGAL Antibody Market Size Growth (2021-2026)
4.5 Europe NGAL Antibody Market Size Growth (2021-2026)
4.6 Middle East & Africa NGAL Antibody Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas NGAL Antibody Market Size by Country (2021-2026)
5.2 Americas NGAL Antibody Market Size by Type (2021-2026)
5.3 Americas NGAL Antibody Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC NGAL Antibody Market Size by Region (2021-2026)
6.2 APAC NGAL Antibody Market Size by Type (2021-2026)
6.3 APAC NGAL Antibody Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe NGAL Antibody Market Size by Country (2021-2026)
7.2 Europe NGAL Antibody Market Size by Type (2021-2026)
7.3 Europe NGAL Antibody Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa NGAL Antibody by Region (2021-2026)
8.2 Middle East & Africa NGAL Antibody Market Size by Type (2021-2026)
8.3 Middle East & Africa NGAL Antibody Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NGAL ANTIBODY MARKET FORECAST

10.1 Global NGAL Antibody Forecast by Region (2027-2032)
  10.1.1 Global NGAL Antibody Forecast by Region (2027-2032)
  10.1.2 Americas NGAL Antibody Forecast
  10.1.3 APAC NGAL Antibody Forecast
  10.1.4 Europe NGAL Antibody Forecast
  10.1.5 Middle East & Africa NGAL Antibody Forecast
10.2 Americas NGAL Antibody Forecast by Country (2027-2032)
  10.2.1 United States Market NGAL Antibody Forecast
  10.2.2 Canada Market NGAL Antibody Forecast
  10.2.3 Mexico Market NGAL Antibody Forecast
  10.2.4 Brazil Market NGAL Antibody Forecast
10.3 APAC NGAL Antibody Forecast by Region (2027-2032)
  10.3.1 China NGAL Antibody Market Forecast
  10.3.2 Japan Market NGAL Antibody Forecast
  10.3.3 Korea Market NGAL Antibody Forecast
  10.3.4 Southeast Asia Market NGAL Antibody Forecast
  10.3.5 India Market NGAL Antibody Forecast
  10.3.6 Australia Market NGAL Antibody Forecast
10.4 Europe NGAL Antibody Forecast by Country (2027-2032)
  10.4.1 Germany Market NGAL Antibody Forecast
  10.4.2 France Market NGAL Antibody Forecast
  10.4.3 UK Market NGAL Antibody Forecast
  10.4.4 Italy Market NGAL Antibody Forecast
  10.4.5 Russia Market NGAL Antibody Forecast
10.5 Middle East & Africa NGAL Antibody Forecast by Region (2027-2032)
  10.5.1 Egypt Market NGAL Antibody Forecast
  10.5.2 South Africa Market NGAL Antibody Forecast
  10.5.3 Israel Market NGAL Antibody Forecast
  10.5.4 Turkey Market NGAL Antibody Forecast
10.6 Global NGAL Antibody Forecast by Type (2027-2032)
10.7 Global NGAL Antibody Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market NGAL Antibody Forecast

11 KEY PLAYERS ANALYSIS

11.1 Thermo Fisher Scientific
  11.1.1 Thermo Fisher Scientific Company Information
  11.1.2 Thermo Fisher Scientific NGAL Antibody Product Offered
  11.1.3 Thermo Fisher Scientific NGAL Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Thermo Fisher Scientific Main Business Overview
  11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Abcam
  11.2.1 Abcam Company Information
  11.2.2 Abcam NGAL Antibody Product Offered
  11.2.3 Abcam NGAL Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Abcam Main Business Overview
  11.2.5 Abcam Latest Developments
11.3 Hytest
  11.3.1 Hytest Company Information
  11.3.2 Hytest NGAL Antibody Product Offered
  11.3.3 Hytest NGAL Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Hytest Main Business Overview
  11.3.5 Hytest Latest Developments
11.4 Enzo Life Sciences
  11.4.1 Enzo Life Sciences Company Information
  11.4.2 Enzo Life Sciences NGAL Antibody Product Offered
  11.4.3 Enzo Life Sciences NGAL Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Enzo Life Sciences Main Business Overview
  11.4.5 Enzo Life Sciences Latest Developments
11.5 Biorbyt
  11.5.1 Biorbyt Company Information
  11.5.2 Biorbyt NGAL Antibody Product Offered
  11.5.3 Biorbyt NGAL Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Biorbyt Main Business Overview
  11.5.5 Biorbyt Latest Developments
11.6 Proteintech
  11.6.1 Proteintech Company Information
  11.6.2 Proteintech NGAL Antibody Product Offered
  11.6.3 Proteintech NGAL Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Proteintech Main Business Overview
  11.6.5 Proteintech Latest Developments
11.7 Biomatik
  11.7.1 Biomatik Company Information
  11.7.2 Biomatik NGAL Antibody Product Offered
  11.7.3 Biomatik NGAL Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Biomatik Main Business Overview
  11.7.5 Biomatik Latest Developments
11.8 Bio-Techne
  11.8.1 Bio-Techne Company Information
  11.8.2 Bio-Techne NGAL Antibody Product Offered
  11.8.3 Bio-Techne NGAL Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Bio-Techne Main Business Overview
  11.8.5 Bio-Techne Latest Developments
11.9 MyBioSource
  11.9.1 MyBioSource Company Information
  11.9.2 MyBioSource NGAL Antibody Product Offered
  11.9.3 MyBioSource NGAL Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 MyBioSource Main Business Overview
  11.9.5 MyBioSource Latest Developments
11.10 GenScript
  11.10.1 GenScript Company Information
  11.10.2 GenScript NGAL Antibody Product Offered
  11.10.3 GenScript NGAL Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 GenScript Main Business Overview
  11.10.5 GenScript Latest Developments
11.11 Bioss
  11.11.1 Bioss Company Information
  11.11.2 Bioss NGAL Antibody Product Offered
  11.11.3 Bioss NGAL Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Bioss Main Business Overview
  11.11.5 Bioss Latest Developments
11.12 BioNC
  11.12.1 BioNC Company Information
  11.12.2 BioNC NGAL Antibody Product Offered
  11.12.3 BioNC NGAL Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 BioNC Main Business Overview
  11.12.5 BioNC Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. NGAL Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. NGAL Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal Antibody
Table 4. Major Players of Polyclonal Antibody
Table 5. NGAL Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global NGAL Antibody Market Size by Type (2021-2026) & ($ millions)
Table 7. Global NGAL Antibody Market Size Market Share by Type (2021-2026)
Table 8. NGAL Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global NGAL Antibody Market Size by Application (2021-2026) & ($ millions)
Table 10. Global NGAL Antibody Market Size Market Share by Application (2021-2026)
Table 11. Global NGAL Antibody Revenue by Player (2021-2026) & ($ millions)
Table 12. Global NGAL Antibody Revenue Market Share by Player (2021-2026)
Table 13. NGAL Antibody Key Players Head office and Products Offered
Table 14. NGAL Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global NGAL Antibody Market Size by Region (2021-2026) & ($ millions)
Table 18. Global NGAL Antibody Market Size Market Share by Region (2021-2026)
Table 19. Global NGAL Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global NGAL Antibody Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas NGAL Antibody Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas NGAL Antibody Market Size Market Share by Country (2021-2026)
Table 23. Americas NGAL Antibody Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas NGAL Antibody Market Size Market Share by Type (2021-2026)
Table 25. Americas NGAL Antibody Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas NGAL Antibody Market Size Market Share by Application (2021-2026)
Table 27. APAC NGAL Antibody Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC NGAL Antibody Market Size Market Share by Region (2021-2026)
Table 29. APAC NGAL Antibody Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC NGAL Antibody Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe NGAL Antibody Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe NGAL Antibody Market Size Market Share by Country (2021-2026)
Table 33. Europe NGAL Antibody Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe NGAL Antibody Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa NGAL Antibody Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa NGAL Antibody Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa NGAL Antibody Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of NGAL Antibody
Table 39. Key Market Challenges & Risks of NGAL Antibody
Table 40. Key Industry Trends of NGAL Antibody
Table 41. Global NGAL Antibody Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global NGAL Antibody Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global NGAL Antibody Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global NGAL Antibody Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Thermo Fisher Scientific Details, Company Type, NGAL Antibody Area Served and Its Competitors
Table 46. Thermo Fisher Scientific NGAL Antibody Product Offered
Table 47. Thermo Fisher Scientific NGAL Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Thermo Fisher Scientific Main Business
Table 49. Thermo Fisher Scientific Latest Developments
Table 50. Abcam Details, Company Type, NGAL Antibody Area Served and Its Competitors
Table 51. Abcam NGAL Antibody Product Offered
Table 52. Abcam NGAL Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Abcam Main Business
Table 54. Abcam Latest Developments
Table 55. Hytest Details, Company Type, NGAL Antibody Area Served and Its Competitors
Table 56. Hytest NGAL Antibody Product Offered
Table 57. Hytest NGAL Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Hytest Main Business
Table 59. Hytest Latest Developments
Table 60. Enzo Life Sciences Details, Company Type, NGAL Antibody Area Served and Its Competitors
Table 61. Enzo Life Sciences NGAL Antibody Product Offered
Table 62. Enzo Life Sciences NGAL Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Enzo Life Sciences Main Business
Table 64. Enzo Life Sciences Latest Developments
Table 65. Biorbyt Details, Company Type, NGAL Antibody Area Served and Its Competitors
Table 66. Biorbyt NGAL Antibody Product Offered
Table 67. Biorbyt NGAL Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Biorbyt Main Business
Table 69. Biorbyt Latest Developments
Table 70. Proteintech Details, Company Type, NGAL Antibody Area Served and Its Competitors
Table 71. Proteintech NGAL Antibody Product Offered
Table 72. Proteintech NGAL Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Proteintech Main Business
Table 74. Proteintech Latest Developments
Table 75. Biomatik Details, Company Type, NGAL Antibody Area Served and Its Competitors
Table 76. Biomatik NGAL Antibody Product Offered
Table 77. Biomatik NGAL Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Biomatik Main Business
Table 79. Biomatik Latest Developments
Table 80. Bio-Techne Details, Company Type, NGAL Antibody Area Served and Its Competitors
Table 81. Bio-Techne NGAL Antibody Product Offered
Table 82. Bio-Techne NGAL Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Bio-Techne Main Business
Table 84. Bio-Techne Latest Developments
Table 85. MyBioSource Details, Company Type, NGAL Antibody Area Served and Its Competitors
Table 86. MyBioSource NGAL Antibody Product Offered
Table 87. MyBioSource NGAL Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. MyBioSource Main Business
Table 89. MyBioSource Latest Developments
Table 90. GenScript Details, Company Type, NGAL Antibody Area Served and Its Competitors
Table 91. GenScript NGAL Antibody Product Offered
Table 92. GenScript NGAL Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. GenScript Main Business
Table 94. GenScript Latest Developments
Table 95. Bioss Details, Company Type, NGAL Antibody Area Served and Its Competitors
Table 96. Bioss NGAL Antibody Product Offered
Table 97. Bioss NGAL Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Bioss Main Business
Table 99. Bioss Latest Developments
Table 100. BioNC Details, Company Type, NGAL Antibody Area Served and Its Competitors
Table 101. BioNC NGAL Antibody Product Offered
Table 102. BioNC NGAL Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. BioNC Main Business
Table 104. BioNC Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. NGAL Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NGAL Antibody Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. NGAL Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. NGAL Antibody Sales Market Share by Country/Region (2025)
Figure 8. NGAL Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global NGAL Antibody Market Size Market Share by Type in 2025
Figure 10. NGAL Antibody in Clinic
Figure 11. Global NGAL Antibody Market: Clinic (2021-2026) & ($ millions)
Figure 12. NGAL Antibody in Scientific Research
Figure 13. Global NGAL Antibody Market: Scientific Research (2021-2026) & ($ millions)
Figure 14. Global NGAL Antibody Market Size Market Share by Application in 2025
Figure 15. Global NGAL Antibody Revenue Market Share by Player in 2025
Figure 16. Global NGAL Antibody Market Size Market Share by Region (2021-2026)
Figure 17. Americas NGAL Antibody Market Size 2021-2026 ($ millions)
Figure 18. APAC NGAL Antibody Market Size 2021-2026 ($ millions)
Figure 19. Europe NGAL Antibody Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa NGAL Antibody Market Size 2021-2026 ($ millions)
Figure 21. Americas NGAL Antibody Value Market Share by Country in 2025
Figure 22. United States NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC NGAL Antibody Market Size Market Share by Region in 2025
Figure 27. APAC NGAL Antibody Market Size Market Share by Type (2021-2026)
Figure 28. APAC NGAL Antibody Market Size Market Share by Application (2021-2026)
Figure 29. China NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 33. India NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe NGAL Antibody Market Size Market Share by Country in 2025
Figure 36. Europe NGAL Antibody Market Size Market Share by Type (2021-2026)
Figure 37. Europe NGAL Antibody Market Size Market Share by Application (2021-2026)
Figure 38. Germany NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 39. France NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 40. UK NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa NGAL Antibody Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa NGAL Antibody Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa NGAL Antibody Market Size Market Share by Application (2021-2026)
Figure 46. Egypt NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries NGAL Antibody Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 52. APAC NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 53. Europe NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 55. United States NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 56. Canada NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 57. Mexico NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 58. Brazil NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 59. China NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 60. Japan NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 61. Korea NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 63. India NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 64. Australia NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 65. Germany NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 66. France NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 67. UK NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 68. Italy NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 69. Russia NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 70. Egypt NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 71. South Africa NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 72. Israel NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 73. Turkey NGAL Antibody Market Size 2027-2032 ($ millions)
Figure 74. Global NGAL Antibody Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global NGAL Antibody Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries NGAL Antibody Market Size 2027-2032 ($ millions)